HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Conditions: Type 2 Diabetes
Interventions: Drug: HP-211; Drug: Placebo
Sponsors: Housey Healthcare ULC
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 24, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments